Tacrolimus (FK 506), a Treatment for Primary Sclerosing Cholangitis: Results of an Open‐Label Preliminary Trial

The American Journal of Gastroenterology

Volumn 90, Issue 3, 1995, Pages 455-459

  Van Thiel, David H ^a,b   Carroll, Patricia ^a,b   Abu‐Elmagd, Kareem ^a,b   Rodriguez‐Rilo, Horacio ^a,b   Irish, William ^a,b   McMichael, John ^a,b   Starzl, Thomas E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MALE; ORAL DRUG ADMINISTRATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOPSY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; ENZYME TESTS; FEMALE; HUMAN; LIVER; MALE; TACROLIMUS; TIME FACTORS;

EID: 0028939546     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1995.tb08243.x     Document Type: Article

References (47)

1. Clinicopathologic fealurcs of the syndrome of primary sclerosing cholangitis
2. Primary sclerosing chnlangitis: A review of its clinical features, cholangiography and hepatic histology
3. Sclerosing cholangilis in ulcerative colilis: A follow‐up study
4. Primary sclerosing cholangitis
5. The syndrome of disappearing bile ducts
6. The syndrome of primary sclerosing cholangifis
7. Advances in primary sclerosing cholangitis
8. Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis
9. Primaryn sclerosing cholangitis. Findings on cholangiography and pancreatography
10. Cholangiocareinoma complicating primary sclerosing cholungitic cholangiographic appearance
11. Morphologic features of chronic hepatitis associated with sclerosing cholangitis and chronic ulcerative colitis
12. Thayer WP Jr. Ekevated circulating immune complexes in primary sclerosing cholangitis
13. Association of primary sclerosing cholangilis with HLA B8
14. Familiar occurrence of primary sclerosing cholangilis and ulcerativc colitis
15. Immonologic analysis of mononuclear cells in liver tissue and blood of patients wish primary sclerosing cholangitis
16. Family incidence of primary sclerosing cholangilis associated with immunological diseases
17. Experience of HLA Dr antigens in the bile duet epithelium in primary sclerosing cholangitis
18. Activation of the complement system in primary sclerosing cholangitis
19. Anti‐neutrophil nuclear antibody in ulceralive colilis. Crohn's disease and primary sclerosinp cholangilis
20. Different immune mechanisms leading in autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood
21. Association of primary sclerosing cholangitis with HLA DrW52a
22. The liver in ulcerative colitis, Treatment of pericholangitis with tetracyclinc
23. Beneficial effect of cholestyramine in sclerosing cholangitis
24. Primary′ sclerosing cholangitis. Complete gross and histologic renewal after long term steroid therapy
25. Effect of long term tetracycline therapy. steroid therapy and coleclomy in pericholangitis for chronic ulcerative colilis as the natural history of primary sclerosing cholangitis
26. Prospective trial of penicillamine‐in primary sclerosing cholangilis
27. Penicillamine and colchicine are not of benefit after ten years in patients with primary sclerosing cholangilis
28. Azathioprine treatment in primary sclerosing cholangitis
29. Azathioprine in primary sclerosing cholangilis
30. Primary sclerosing cholangilis and low dose oral pulse methutrexale therapy. Clinical and histologie responses
31. The effect of ursodeoxy‐cholic acid in primary sclerosing cholangitis
32. Ursodeoxycholic acid for the treatment of primary sclerosing cholan‐gitis: A 30‐month pilot study
33. Asymptomatic primary sclerosing cholangilis treated with Ursodeoxycholic acid
34. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial
35. Primary sclerosing cholangitis: The emerging rote for liver transplantation
36. Orthotopic liver transplantaion for primary sclcrosing cholangitis
37. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis
38. FK 506 assay past and present characteristics of FK 506 ELISA
39. FK 5116: Historical perspectives
40. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs. cy‐dosporine
41. FK 506 in clinical kidney lransplantation
42. Clinical small bowel or small bowel plus liver transplantation under FK 506
43. Use of FK 506 for treatment of chronic rejection after liver transplantation
44. FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients
45. FK 50ft rescue therapy in liver transplant recipients with drug‐resistant rejection
46. FK 506: Reversal of Immorally mediated rejection following ABO‐incompatible liver transplantation
47. FK 506 rescue treatment of adult and chronic rejection of liver allografl recipients